Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640705 · ClinicalTrials.gov registry record · Phase 2
Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain
A Phase 2 study, sponsored by Cerimon Pharmaceuticals.
- Terminated
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
NCT00640705 is a Phase 2 study that was terminated before completion, run by Cerimon Pharmaceuticals. The registered enrollment target is 170 participants.
The verdict
NCT00640705, a Phase 2 study, was terminated before completion, sponsored by Cerimon Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be either the left or right ankle. The secondary purpose of this study is to assess the safety and tolerability of a diclofenac patch on the skin.
Interventions
- DRUG diclofenac sodium
- DRUG Matching placebo patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00640705
The ClinicalTrials.gov registry entry for NCT00640705 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cerimon Pharmaceuticals, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which diclofenac sodium is the first listed.
NCT00640705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00640705 about?
NCT00640705 is a clinical study titled "Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain". The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be either the left or right ankle. The secondary purpose of this study is to assess the s...
What is the current status of trial NCT00640705?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2008-01. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00640705?
The interventions under investigation include: diclofenac sodium (DRUG), Matching placebo patch (DRUG).
Who is sponsoring clinical trial NCT00640705?
This trial is sponsored by Cerimon Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.